HR 4626 United States House · 118th Congress

OTC Act of 2023

Summary
Orally Taken Contraception Act of 2023 or the OTC Act of 2023 This bill requires the Food and Drug Administration (FDA) to issue guidance on the approval process for over-the-counter oral contraceptives so as to encourage drug manufacturers to submit applications for approval. The FDA must also evaluate (1) whether and to what extent consumers understand the labeling on oral contraceptives, and (2) whether the labeling could be improved.
Bill status in committee 1 of 4 stages cleared
Introduction
Jul 2023
Committee Review
Floor Vote
President
Introduced Jul 13, 2023 Last action Jul 14, 2023
Floor votes

How they voted

No floor votes recorded yet.
Full legislative history

Actions timeline

Total actions
3
Key actions
0
Committee
2
Jul 14, 2023
Committee
Referred to the Subcommittee on Health.
lower
Jul 13, 2023
Committee
Referred to the House Committee on Energy and Commerce.
lower
Jul 13, 2023
Introduced
Introduced in House
lower
1 primary · 10 co-sponsors

Sponsors